References
- Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 121: 182-205.
- Llata E, Gaynes RP, Fridkin S. Measuring the scope and magnitude of hospital-associated infection in the United States: the value of prevalence surveys. Clin Infect Dis 2009; 48: 1434-40.
- Humphreys H, Smyth ET. Prevalence surveys of healthcare-associated infections: what do they tell us, if anything? Clin Microbiol Infect 2006; 12: 2-4.
- Klavs I, Bufon Lužnik T, Škerl M, Grgič-Vitek M, Lejko Zupanc T, Dolinšek M, et al. Prevalance of and risk factors for hospital-acquired infections in Slovenia-results of the first national survey, 2001. J Hosp Infect 2003; 54: 149-57.
- Klavs I, Kolman J, Lejko Zupanc T, Kotnik-Kevorkijan B, Korosec A, Serdt M, et al. Prevalence of and risk factors for healthcare-associated infections in Slovenia - results of the second national survey. Zdrav Var 2016; 55(4)
- European Centre for Disease Control (ECDC). Point prevalence survey of healthcare - associated infections and antimicrobial use in European acute care hospitals - protocol version 4. 3. Stockholm: ECDC; 2012. Available Dec 22, 2015 from: http://ecdc.europa.eu/en/publications/publications/0512-ted-pps-hai-antimicrobial-use-protocol.pdf.
- Gastmeier P, Kampf G, Hauer T, Schlingmann J, Schumacher M, Daschner F, et al. Experience with two validation methods in a prevalence survey on nosocomial infections. Infect Control Hosp Epidemiol 1998; 19: 668-73.
- McCoubrey J, Reilly J, Pollock KG, Johnston F. Validation of surgical site infection surveillance data in Scotland. J Hosp Infect 2005; 61: 194-200.
- Mannien J, van der Zeeuw AE, Wille JC, van den Hof S. Validation of surgical site infection surveillance in the Netherlands. Infect Control Hosp Epidemiol 2007; 28: 36-41.
- Fabry J, Morales I, Metzger MH, Russell I, Gastmeier P. Quality of information: a European challenge. J Hosp Infect. 2007; 65(2): 155-8.
- Reilly JS, Price L, Godwin J, Cairns S, Hopkins S, Cookson B, et al. A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011. Euro Surveill 2015; 20: pii=21045.
- McCabe WR, Jackson GG. Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med 1963; 110: 847-55.
- European Centre for Disease Control (ECDC). PPS Validation Protocol Version 2.1. Stockholm: ECDC; 2014. Available Dec 23, 2015 from: http://ecdc.europa.eu/en/publications/Publications/HAI-PPS-Validation-protocol-Sept-2014.pdf.
- Banerjee M, Capozzoli M, McSweeney L, Sinha D. Beyond kappa: a review of interrater agreement measures. Can J Stat 1999; 27: 3-23.
- Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.